IL6 and metabolic syndrome: Additionally, future research should consider adipose tissue parameters alongside other clinical variables—such as metabolic syndrome components, systemic inflammatory markers (e.g., CRP, IL-6), and genetic or epigenetic factors—to develop comprehensive, multifactorial risk prediction models.